002728 特一药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.6561.08614.83213.37510.838
总资产报酬率 ROA (%)2.8220.83410.0107.7285.873
投入资产回报率 ROIC (%)2.9340.86910.5358.1316.095

边际利润分析
销售毛利率 (%)56.94043.92056.14949.03653.034
营业利润率 (%)10.5773.50727.48022.16918.541
息税前利润/营业总收入 (%)11.0573.10227.90624.55722.568
净利润/营业总收入 (%)9.4262.98023.72320.10016.740

收益指标分析
经营活动净收益/利润总额(%)86.992117.108101.83996.315105.423
价值变动净收益/利润总额(%)1.00116.9410.1230.1734.288
营业外收支净额/利润总额(%)2.208-9.364-0.095-0.1144.439

偿债能力分析
流动比率 (X)2.0081.5952.3731.0181.434
速动比率 (X)1.3261.1521.7890.8301.041
资产负债率 (%)18.80926.48819.97744.88038.937
带息债务/全部投入资本 (%)13.33422.26314.62540.37334.940
股东权益/带息债务 (%)636.813341.446573.437144.273182.876
股东权益/负债合计 (%)431.664277.530400.570122.817156.828
利息保障倍数 (X)45.976-29.78661.72510.1797.128

营运能力分析
应收账款周转天数 (天)33.47251.44032.26234.60835.089
存货周转天数 (天)237.444250.233184.643160.762196.319